1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Regulation

FDA Finalizes Voluntary Improvement Program Guidance Document

 
• By Elizabeth Orr

The US FDA has finalized a guidance document on the Voluntary Improvement Program, which aims to help manufacturers continuously improve quality and compliance.

Businessman holding card that says "VIP Member."
• Source: Shutterstock

The US Food and Drug Administration has finalized a guidance document on the Voluntary Improvement Program (VIP), an agency initiative that encourages manufacturers to work with third parties to improve device quality and performance.

The program is an offshoot of the Case for Quality and Case for Quality Pilot, earlier Center for Devices and Radiological Health (CDRH) projects that explored the best strategies to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

FDA Rebukes Four Companies, Including One Overseas, For Procedural Failures

 
• By Brian Bossetta

The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.

EU Finalizes Framework For Joint Clinical Assessments Of High-Risk Devices

 
• By Amanda Maxwell

Second submission window for joint scientific consultations on a procedure to help prepare for joint clinical assessments will open from 2 to 30 June 2025.

Get Ready For International Harmonization Before Approaching QMSR Deadline, Says Regulatory Expert

 
• By Brian Bossetta

During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.